Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-17-001665
Filing Date
2017-04-13
Accepted
2017-04-13 16:31:37
Documents
69
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K s105661_10k.htm 10-K 890592
2 EXHIBIT 23.01 s105661_ex23-01.htm EX-23.01 2346
3 EXHIBIT 31.01 s105661_ex31-01.htm EX-31.01 11001
4 EXHIBIT 31.02 s105661_ex31-02.htm EX-31.02 10901
5 EXHIBIT 32.01 s105661_ex32-01.htm EX-32.01 5462
  Complete submission text file 0001615774-17-001665.txt   4447710

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE tnxp-20161231.xml EX-101.INS 745118
7 XBRL SCHEMA FILE tnxp-20161231.xsd EX-101.SCH 45043
8 XBRL CALCULATION FILE tnxp-20161231_cal.xml EX-101.CAL 55033
9 XBRL DEFINITION FILE tnxp-20161231_def.xml EX-101.DEF 183111
10 XBRL LABEL FILE tnxp-20161231_lab.xml EX-101.LAB 374502
11 XBRL PRESENTATION FILE tnxp-20161231_pre.xml EX-101.PRE 291269
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 17760968
SIC: 2834 Pharmaceutical Preparations